The company’s gross profit for the quarter was $3.5 million — up 31 percent from the year before. Fuse’s net income also increased by $630,524.
Fuse’s growth plan for 2023 and 2024 is to focus on the design and development of new orthopedic and spinal devices for commercialization and expand its national distribution footprint, according to an Aug. 15 press release.
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 18–20 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
